Clinical Trials in Los Angeles

Showing 12181-12200 of 14,465 trials

Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer

NCT00022373

RATIONALE: Iseganan hydrochloride may be effective in preventing or lessening oral mucositis in patients who are receiving radiation therapy for head and neck cancer. It is not yet known if iseganan hydrochloride is effective in preventing oral mucositis. PURPOSE: Randomized phase III trial to determine the effectiveness of iseganan hydrochloride in preventing oral mucositis in patients who are receiving radiation therapy for head and neck cancer.

Head and Neck CancerOral Complications of Radiation TherapyRadiation Toxicity

National Cancer Institute (NCI)Started Dec 2000

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

VEC-162 Study in Adult Patients With Primary Insomnia

NCT00548340

The purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with primary insomnia.

Primary Insomnia

Vanda Pharmaceuticals322 participantsStarted Nov 2007

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States +32 more locations

Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer

VEC-162 Study in Adult Patients With Primary Insomnia

Find Trials by Condition in Los Angeles

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Pharmacodynamics of CNP During Growth Hormone Treatment

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

Experimental Medication For the Treatment of Generalized Anxiety Disorder

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer